ロード中...
The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies
Rituximab (RTX) is an effective treatment for refractory nephrotic syndrome (NS), but may produce human anti-chimeric antibodies (HACA) which can cause severe infusion reaction or rituximab-induced serum sickness (RISS). RISS presents with a fever, rash, and arthralgia, which typically occurs 7–21 d...
保存先:
| 出版年: | CEN Case Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Singapore
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7502089/ https://ncbi.nlm.nih.gov/pubmed/32535844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00492-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|